au.\*:("WALSH, E. E")
Results 1 to 25 of 36
Selection :
Mucosal immunization with a subunit respiratory syncytial virus vaccine in miceWALSH, E. E.Vaccine. 1993, Vol 11, Num 11, pp 1135-1138, issn 0264-410XArticle
Intermittent compression pump for nonhealing wounds in patients with limb ischemia: The Mayo Clinic experience (1998-2000)MONTORI, V. M; KAVROS, S. J; WALSH, E. E et al.International angiology. 2002, Vol 21, Num 4, pp 360-366, issn 0392-9590, 7 p.Article
Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adultsFALSEY, A. R; WALSH, E. E; LOONEY, R. J et al.Journal of medical virology. 1999, Vol 59, Num 2, pp 221-226, issn 0146-6615Article
Viral respiratory infections in the institutionalized elderly : clinical and epidemiologic findingsFALSEY, A. R; TREANOR, J. J; BETTS, R. F et al.Journal of the American Geriatrics Society. 1992, Vol 40, Num 2, pp 115-119, issn 0002-8614Article
Immunity to and frequency of reinfection with respiratory syncytial virusHALL, C. B; WALSH, E. E; LONG, C. E et al.The Journal of infectious diseases. 1991, Vol 163, Num 4, pp 693-698, issn 0022-1899, 6 p.Article
Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infectionMURPHY, B. R; GRAHAM, B. S; PRINCE, G. A et al.Journal of clinical microbiology (Print). 1986, Vol 23, Num 6, pp 1009-1014, issn 0095-1137Article
Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48SCHLESINGER, J. L; BRANDRISS, M. W; WALSH, E. E et al.The Journal of immunology (1950). 1985, Vol 135, Num 4, pp 2805-2809, issn 0022-1767Article
Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adultsGONZALEZ, I. M; KARRON, R. A; EICHELBERGER, M et al.Vaccine. 2000, Vol 18, Num 17, pp 1763-1772, issn 0264-410XArticle
Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderlyFALSEY, A. R; WALSH, E. E.Vaccine. 1997, Vol 15, Num 10, pp 1130-1132, issn 0264-410XArticle
Respiratory syncytial virus infection in the elderlyMLINARIC-GALINOVIC, G; FALSEY, A. R; WALSH, E. E et al.European journal of clinical microbiology & infectious diseases (Print). 1996, Vol 15, Num 10, pp 777-781, issn 0934-9723Article
Occurence of groups A and B of respiratory syncytial virus over 15 years associated epidemiologic and clinical characteristics in hospitalized and ambulatory childrenBREESE HALL, C; WALSH, E. E; SCHNABEL, K. V et al.The Journal of infectious diseases. 1990, Vol 162, Num 6, pp 1283-1290, issn 0022-1899Article
Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adultsWAGNER, D. K; NELSON, D. L; WALSH, E. E et al.Journal of clinical microbiology (Print). 1987, Vol 25, Num 4, pp 748-750, issn 0095-1137Article
Protection of mice against 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1SCHLESINGER, J. J; BRANDRISS, M. W; WALSH, E. E et al.Journal of general virology. 1987, Vol 68, Num 3, pp 853-857, issn 0022-1317Article
Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in childrenKASEL, J. A; WALSH, E. E; FRANK, A. L et al.Viral immunology. 1987, Vol 1, Num 3, pp 199-205, issn 0882-8245Article
Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodiesWALSH, E. E; COTE, P. J; FERNIE, B. F et al.Journal of general virology. 1986, Vol 67, pp 505-513, issn 0022-1317, 3Article
Purification and characterization of the respiratory syncytial virus fusion proteinWALSH, E. E; BRANDRISS, M. W; SCHLESINGER, J. J et al.Journal of general virology. 1985, Vol 66, Num 3, pp 409-415, issn 0022-1317Article
Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunitOIEN, N. L; BRIDEAU, R. J; WALSH, E. E et al.Vaccine. 1994, Vol 12, Num 8, pp 731-735, issn 0264-410XArticle
Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infectionsWAGNER, D. K; MUELENAER, P; HENDERSON, F. W et al.Journal of clinical microbiology (Print). 1989, Vol 27, Num 3, pp 589-592, issn 0095-1137Article
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunityJOHNSON, P. R. JR; OLMSTED, R. A; PRINCE, G. A et al.Journal of virology. 1987, Vol 61, Num 10, pp 3163-3166, issn 0022-538XArticle
Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infectionWALSH, E. E; HALL, C. B; BRISELLI, M et al.The Journal of infectious diseases. 1987, Vol 155, Num 6, pp 1198-1204, issn 0022-1899Article
Macrophages are required for influenza virus infection of human lymphocytesMOCK, D. J; DOMURAT, F; ROBERTS, N. J. JR et al.The Journal of clinical investigation. 1987, Vol 79, Num 2, pp 620-624, issn 0021-9738Article
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccineMURPHY, B. R; PRINCE, G. A; WALSH, E. E et al.Journal of clinical microbiology (Print). 1986, Vol 24, Num 2, pp 197-202, issn 0095-1137Article
Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivoDOMURAT, F; ROBERTS, N. J. JR; WALSH, E. E et al.The Journal of infectious diseases. 1985, Vol 152, Num 5, pp 895-902, issn 0022-1899Article
Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate modelHEMMING, V. G; PRINCE, G. A; HORSWOOD, R. L et al.The Journal of infectious diseases. 1985, Vol 152, Num 5, pp 1083-1087, issn 0022-1899Article
